Contact Information
Company Information
Company
Ratio Therapeutics
Professional Summary
Jack Hoppin serves as CEO at Ratio Therapeutics. Ratio Therapeutics operates in the research sector with approximately 56.0 employees. The company is headquartered in Boston, Massachusetts. Ratio Therapeutics generates annual revenue of 1500000.0. To date, Ratio Therapeutics has raised 90000000.0 in total funding, with the most recent round being Series B.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
3,781 executive contacts are available in Massachusetts.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Google Tag Manager
Wordpress.com
Nginx
Mobile Friendly
WordPress.org
Render
Remote
AI
Keywords
biotechnology research
radiopharmaceuticals
cancer treatment
theranostics
targeted therapy
sstr2-targeting
alpha-emitting radionuclides
companion diagnostics
pharmacokinetics modulation
clinical trials
fap-targeted therapy
tumor delivery
tumor-killing
preclinical development
drug development
innovative technologies
imaging & therapeutic
antibody drug conjugates
oncology
fibroblast activation protein
novel drug candidates
partnerships with pharma
clinical studies
biotechnology
drug discovery
cancer differentiation
radioligand therapy
pipeline development
biopharmaceuticals
regulatory science
licensing agreements
collaboration with novartis
tunable compounds
proprietary technology
biotech innovation
small molecule targeting agents
chemical compatibility
drug availability
in vivo stability
multimodal approaches
tumor penetration
radionuclide therapy
patient-centric treatment
advanced cancer therapies
personalized medicine
disease-specific diagnostics
market position
research & development
target identification
clinical operations
academic collaboration
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like Jack Hoppin in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Ratio Therapeutics.
Jack Hoppin's Position in the MessageCEO Database
- •Jack Hoppin is 1 of 1 verified executive contact we track at Ratio Therapeutics.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •3,577 verified executive contacts in Massachusetts are in the database.
- •17 verified contacts work at research companies in the 56.0 employee range (same size as Ratio Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Jack Hoppin directly?
Jack Hoppin's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Ratio Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Jack Hoppin work for?
Jack Hoppin is CEO at Ratio Therapeutics, a company in the research sector with 56.0 employees. The company is based in Boston, Massachusetts.
Can I pitch or sell to Jack Hoppin?
As CEO at Ratio Therapeutics, Jack Hoppin is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Jack Hoppin directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Jack Hoppin in?
Jack Hoppin works in the research industry as CEO at Ratio Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Jack Hoppin's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jack Hoppin's profile is kept up-to-date with the latest available information.
Last updated: July 18, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans